Trandolapril and Verapamil

Interactions with herbs

Cayenne

Licorice

Interactions with supplements

Look Up > Drugs > Trandolapril and Verapamil

Trandolapril and Verapamil

	Pronunciation
	U.S. Brand Names
	Generic Available
	Pharmacological Index
	Use
	Pregnancy Risk Factor

	Usual Dosage
	Cardiovascular Considerations
	Dental Health: Local Anesthetic/Vasoconstrictor Precautions
	Dental Health: Effects on Dental Treatment
	Patient Information
	Dosage Forms

Pronunciation

(tran DOE la pril & ver AP a mil)

U.S. Brand Names

Tarka®

Generic Available

Pharmacological Index

Antihypertensive Agent, Combination

Use

Combination drug for the treatment of hypertension, however, not indicated for initial treatment of hypertension; replacement therapy in patients receiving separate dosage forms (for patient convenience); when monotherapy with one component fails to achieve desired antihypertensive effect, or when dose-limiting adverse effects limit upward titration of monotherapy

Pregnancy Risk Factor

C/D (2nd and 3rd trimesters)

Usual Dosage

Dose is individualized

Cardiovascular Considerations

Combination therapy for the treatment of hypertension should be individualized for each patient. Potential advantages for trandolapril and verapamil combination therapy may include improved compliance and synergistic reductions in blood pressure with an accompanied reduction in side effects.

Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions

Dental Health: Effects on Dental Treatment

No effects or complications reported

Patient Information

See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Do not breast-feed.

Dosage Forms

Tablet:

Trandolapril 2 mg and verapamil hydrochloride 180 mg

Trandolapril 2 mg and verapamil hydrochloride 240 mg

Trandolapril 4 mg and verapamil hydrochloride 240 mg